Share chart Medtronic
Extended chart
Simple chart
About Medtronic
Medtronic plc разрабатывает, производит, распространяет и продает медицинские методы лечения на основе устройств больницам, врачам, клиницистам и пациентам по всему миру. Он работает через четыре сегмента: кардиологическую и сосудистую группу, группу минимально инвазивной терапии, группу восстановительной терапии и группу диабета. more detailsIPO date | 1978-01-13 |
---|---|
ISIN | IE00BTN1Y115 |
Industry | Health Care Equipment & Supplies |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 3.49 |
Дивиденд ао | 2.79 |
Сайт | https://www.medtronic.com |
Цена ао | 91.35 |
Change price per day: | 0% (91.35) |
---|---|
Change price per week: | +0.5836% (90.82) |
Change price per month: | +7.16% (85.25) |
Change price per 3 month: | +6.22% (86) |
Change price per half year: | +7.98% (84.6) |
Change price per year: | +9.17% (83.68) |
Change price per 3 year: | -18.63% (112.26) |
Change price per 5 year: | -18.78% (112.47) |
Change price per 10 year: | +14.5% (79.78) |
Change price per year to date: | +12.03% (81.54) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Dividend, % | Dividend | Result of period | Buy before | Register closing date | Payment before |
---|---|---|---|---|---|
0.77% | 0.699 | III кв. 2024 | 25.12.2024 | 27.12.2024 | 13.01.2025 |
0.97% | 0.699 | II кв. 2024 | 25.09.2024 | 27.09.2024 | 14.10.2024 |
0.86% | 0.7 | I кв. 2024 | 26.06.2024 | 28.06.2024 | 15.07.2024 |
0.83% | 0.69 | IV кв. 2023 | 19.03.2024 | 21.03.2024 | 05.04.2024 |
0.86% | 0.69 | III кв. 2023 | 15.12.2023 | 19.12.2023 | 03.01.2024 |
0.85% | 0.69 | II кв. 2023 | 19.09.2023 | 21.09.2023 | 06.10.2023 |
0.82% | 0.69 | I кв. 2023 | 20.06.2023 | 22.06.2023 | 07.07.2023 |
0.89% | 0.68 | IV кв. 2022 | 21.03.2023 | 23.03.2023 | 07.04.2023 |
0.84% | 0.68 | III кв. 2022 | 16.12.2022 | 20.12.2022 | 04.01.2023 |
0.75% | 0.68 | II кв. 2022 | 20.09.2022 | 22.09.2022 | 07.10.2022 |
Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
---|---|---|---|---|---|---|---|---|---|
24.01.2025 | 24.01.2025 | Wall Brett A. Officer |
Purchase | 90 | 1 119 330 | 12437 | 0 | 0 | link |
31.10.2024 | 31.10.2024 | PARKHILL KAREN L Former Director |
Purchase | 89.73 | 2 691 900 | 30000 | 0 | 0 | link |
29.10.2024 | 29.10.2024 | PARKHILL KAREN L Former BOD |
Purchase | 91.16 | 1 367 400 | 15000 | 0 | 0 | link |
24.10.2024 | 24.10.2024 | PARKHILL KAREN L Former Director |
Purchase | 92.49 | 2 100 630 | 22712 | 0 | 0 | link |
17.10.2024 | 17.10.2024 | PARKHILL KAREN L Former BOD |
Purchase | 89.87 | 4 958 940 | 55179 | 0 | 0 | link |
08.04.2024 | 09.04.2024 | Marinaro Michael EVP & President, Surgical OU |
Sale | 83.14 | 71 002 | 854 | 0 | 0 | link |
04.08.2023 | 07.08.2023 | Marinaro Michael EVP & President, Surgical OU |
Sale | 84.11 | 113 717 | 1352 | 0 | 0 | link |
18.03.2022 | 21.03.2022 | PARKHILL KAREN L EVP & Chief Financial Officer |
Sale | 110 | 75 020 | 682 | 0 | 0 | link |
23.12.2021 | 27.12.2021 | WHITE ROBERT JOHN EVP & Pres. Medical Surgical |
Sale | 102.04 | 736 525 | 7218 | 0 | 0 | link |
25.08.2021 | 26.08.2021 | Martha Geoffrey CEO |
Sale | 132.67 | 1 536 450 | 11581 | 0 | 0 | link |
25.08.2021 | 26.08.2021 | Martha Geoffrey CEO |
Purchase | 61.81 | 715 822 | 11581 | 0 | 0 | link |
25.08.2021 | 26.08.2021 | Salmon Sean EVP & Pres Diabetes/Cardiovasc |
Sale | 134.08 | 3 810 420 | 28419 | 0 | 0 | link |
25.08.2021 | 26.08.2021 | Salmon Sean EVP & Pres Diabetes/Cardiovasc |
Purchase | 38.71 | 1 100 100 | 28419 | 0 | 0 | link |
Institutions | Volume | Share, % |
---|---|---|
Vanguard Group Inc | 126548056 | 9.53 |
Blackrock Inc. | 118573188 | 8.93 |
State Street Corporation | 60916129 | 4.59 |
Massachusetts Financial Services Co. | 28887300 | 2.18 |
Capital Research Global Investors | 28840303 | 2.17 |
Geode Capital Management, LLC | 26727530 | 2.01 |
JP Morgan Chase & Company | 25385137 | 1.91 |
Wellington Management Group, LLP | 24011819 | 1.81 |
Morgan Stanley | 23281910 | 1.75 |
Bank of America Corporation | 22563469 | 1.7 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Geoffrey Straub Martha | Chairman of the Board & CEO | 1.79M | 1970 (55 years) |
Mr. Mark Ploof | Senior Vice President of Global Operations and Business Services | N/A | |
Mr. Ryan Weispfenning | VP & Head of Investor Relations | N/A | |
Ms. Jennifer M. Kirk | Senior VP, Global Controller & Chief Accounting Officer | N/A | 1975 (50 years) |
Dr. Laura Mauri M.D., M.Sc. | Senior VP and Chief Scientific & Medical Officer | N/A | |
Dr. Kenneth E. Washington Ph.D. | Senior VP and Chief Technology & Innovation Officer | N/A | 1960 (65 years) |
Mr. Sean M. Salmon | Executive VP & President of Cardiovascular Portfolio | 900.97k | 1965 (60 years) |
Mr. Brett A. Wall | Executive VP & President of Neuroscience Portfolio | 1966 (59 years) | |
Mr. Gregory L. Smith | Executive Vice President of Global Operations & Supply Chain | 1964 (61 year) | |
Gary Corona | Senior Vice President of Global Financial Planning and Analysis & Interim CFO |
Address: Ireland, Dublin , 20 On Hatch - open in Google maps, open in Yandex maps
Website: https://www.medtronic.com
Website: https://www.medtronic.com